EyePoint, Inc. Payments for Restructuring
EyePoint, Inc. (EYPT) reported Payments for Restructuring of $590.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2021-03-12
- EyePoint, Inc. payments for restructuring for the quarter ending 2020-09-30 was $56.00K.
- EyePoint, Inc. payments for restructuring for the quarter ending 2020-06-30 was $264.00K.
- EyePoint, Inc. payments for restructuring for the quarter ending 2017-06-30 was $0.00.
- EyePoint, Inc. payments for restructuring for the quarter ending 2017-03-31 was $40.00K.
- EyePoint, Inc. payments for restructuring for fiscal 2020 was $590.00K.
- EyePoint, Inc. payments for restructuring for fiscal 2017 was $659.00K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2020-12-31 | $590.00K 10-K · filed 2021-03-12 | |||
| 2020-09-30 | $56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-06 | $320.00K 10-Q · filed 2020-11-06 | ||
| 2020-06-30 | $264.00K 10-Q · filed 2020-08-05 | |||
| 2017-06-30 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2019-03-18 | $40.00K derived: sum of 2 quarters · filed 2019-03-18 | $144.00K derived: sum of 3 quarters · filed 2019-03-18 | $659.00K 10-KT · filed 2019-03-18 |
| 2017-03-31 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10 | $144.00K derived: sum of 2 quarters · filed 2018-05-10 | $659.00K 10-Q · filed 2018-05-10 | |
| 2016-12-31 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $619.00K 10-Q · filed 2018-02-08 | ||
| 2016-09-30 | $515.00K 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |